 |
|
 |
Full Year Report 2007
Integration of SCHWARZ PHARMA Business into UCB Group on Target
more
|
|
Interim Report - Nine Months 2007
SCHWARZ PHARMA On Track - SCHWARZ PHARMA achieved net sales of €671.2 million in the first nine months of 2007, marking a year-over-year decrease of -6.8%.
more
|
|
Changes within the Executive Board of SCHWARZ PHARMA AG
Detlef Thielgen, Chief Executive Officer (CEO) and Executive Board Member will resign as of 31. October 2007, in order to focus on his function as Chief Financial Officer (CFO) of UCB S.A. in Brussels.
more
|
|
|  | | |
|
